0 Ratings

ID

14822

Description

Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL; ODM derived from: https://clinicaltrials.gov/show/NCT01562977

Link

https://clinicaltrials.gov/show/NCT01562977

Keywords

  1. 4/29/16 4/29/16 -
Uploaded on

April 29, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Aggressive Lymphoma NCT01562977

    Eligibility Aggressive Lymphoma NCT01562977

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    age ≥ 18 years.
    Description

    age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    dlbcl and mcl diagnosed patients in primary resistance or relapsed not eligible for intensification chemotherapy followed by autologous stem cell transplantation (asct) for age, comorbidity or previous asct.
    Description

    Diffuse Large B-Cell Lymphoma

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079744
    any ipi or ecog, capable of understanding the nature of the trial.
    Description

    ecog

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    writtern informed consent.
    Description

    informed consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    nursing pregnant or lactation period women, or fertile age adults not using effective contraceptive method.
    Description

    pregnant or lactation women

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C2828358
    UMLS CUI [1,2]
    C0549206
    cns lymphoma patients
    Description

    Central nervous system lymphoma

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0742472
    patients with severa renal (creatinine> 2,5 unl) or hepatic (bilirrubin or alt/ast> 2,5 unl) impairement not provided by the same disease
    Description

    renal or hepatic impairement

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0948807
    UMLS CUI [2]
    C0948807
    hiv positive patients.
    Description

    hiv positive

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0019699
    serious psychiatric diseases patients that could interfere with their skill to understand the study (including alcoholism or drug addiction).
    Description

    psychiatric disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0004936
    murine proteins or any other component of the medicines of the study hypersensitivity patients.
    Description

    murine protein

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1699668
    patients who have received more than 2 therapeutic previous lines. (for previous asct patients, induction and conditioning for the taph treatment is considered a single line therapy).
    Description

    patients who have received more than 2 therapeutic previous lines

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0868551

    Similar models

    Eligibility Aggressive Lymphoma NCT01562977

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    age
    Item
    age ≥ 18 years.
    boolean
    C0001779 (UMLS CUI [1])
    Diffuse Large B-Cell Lymphoma
    Item
    dlbcl and mcl diagnosed patients in primary resistance or relapsed not eligible for intensification chemotherapy followed by autologous stem cell transplantation (asct) for age, comorbidity or previous asct.
    boolean
    C0079744 (UMLS CUI [1])
    ecog
    Item
    any ipi or ecog, capable of understanding the nature of the trial.
    boolean
    C1520224 (UMLS CUI [1])
    informed consent
    Item
    writtern informed consent.
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    pregnant or lactation women
    Item
    nursing pregnant or lactation period women, or fertile age adults not using effective contraceptive method.
    boolean
    C2828358 (UMLS CUI [1,1])
    C0549206 (UMLS CUI [1,2])
    Central nervous system lymphoma
    Item
    cns lymphoma patients
    boolean
    C0742472 (UMLS CUI [1])
    renal or hepatic impairement
    Item
    patients with severa renal (creatinine> 2,5 unl) or hepatic (bilirrubin or alt/ast> 2,5 unl) impairement not provided by the same disease
    boolean
    C0948807 (UMLS CUI [1])
    C0948807 (UMLS CUI [2])
    hiv positive
    Item
    hiv positive patients.
    boolean
    C0019699 (UMLS CUI [1])
    psychiatric disease
    Item
    serious psychiatric diseases patients that could interfere with their skill to understand the study (including alcoholism or drug addiction).
    boolean
    C0004936 (UMLS CUI [1])
    murine protein
    Item
    murine proteins or any other component of the medicines of the study hypersensitivity patients.
    boolean
    C1699668 (UMLS CUI [1])
    patients who have received more than 2 therapeutic previous lines
    Item
    patients who have received more than 2 therapeutic previous lines. (for previous asct patients, induction and conditioning for the taph treatment is considered a single line therapy).
    boolean
    C0868551 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial